期刊文献+

美洛昔康用于紧急避孕的系统评价 被引量:3

Systematic Evaluation on Efficiency and Safety of Meloxicam for Emergency Contraception
下载PDF
导出
摘要 目的系统评价美洛昔康用于紧急避孕的有效性和安全性。方法全面检索相关文献,对根据纳入标准筛选后的研究进行严格评价和Meta分析。结果最终纳入3个随机对照试验,Meta分析结果显示,美洛昔康可增大主导卵泡直径可延迟女性排卵时间;试验组和对照组的不良反应发生率比较,差异无统计学意义;美洛昔康30 mg/d的避孕效果优于15 mg/d。结论美洛昔康30 mg/d用于紧急避孕有效且相对安全。但该系统评价纳入的研究样本量较小,现有证据尚不足以推荐此方案广泛用于避孕,还需开展更多大样本随机双盲对照试验加以验证。 Objective To evaluate the effectiveness and safety of meloxicam in emergency contraception. Methods By retrieving all rela- tive literature and screening the researches according to the inclusion criteria,the included researches were performed the strict evalua- tion and Meta analysis. Results 3 randomized controlled trials(RCTs) were included. The meta- analysis Results showed that meloxicam could enlarge the diameter of dominant follicle and delay the female ovulation time. There was no statistically significant difference in the incidence of adverse reactions between the trial group and control group. Meloxicam 30 mg/d was more effective than 15 mg/d. Conclusion Meloxicam 30 mg/d is effective and relatively safe for emergency contraception. However,due to smaller included sample size, the existing evidences are insufficient to recommend this regimen widely used in crowd requiring contraception. Therefore more ran- domized double- blind controlled trials with large sample are required for further verification.
作者 刘光先
出处 《中国药业》 CAS 2012年第18期26-28,共3页 China Pharmaceuticals
关键词 美洛昔康 紧急避孕 系统评价 META分析 meloxicam emergency contraception systematic evaluation Meta - analysis
  • 相关文献

参考文献17

  • 1Skomsvoll JF, Rodevand E, Koksvik HS, et al. Reversible infertility from nonsteroidal anti -inflammatory drugs[J]. Tidsskr Nor Laegeforen, 2005, 125(11):1 476 - 1 478.
  • 2邓珊.非甾体抗炎药对排卵影响的前瞻性随机对照临床试验[J].实用妇产科杂志,2002(2):95.
  • 3Salhab AS, Amro BI, Shomaf MS. Further investigation on meloxicam contraceptivity in female rabbits : luteinizing unruptured follicles, a microscopic evidence [ J ]. Contraception, 2003,67 (6) :485 - 489.
  • 4Salhab AS, Gharaibeh MN, Shomaf MS, et al. Meloxicam inhibits rabbit ovulation [ J ]. Contraception, 2001,63 (6) : 329 - 333.
  • 5Hester K, Harper M, Duffy D. Oral administration of the cyclooxygenase - 2(COX -2) inhibitor meloxicam blocks ovulation in non -human primates when administered to simulate emergency contraception [J]. Hum Reprod, 2010,25(2) : 360 - 367.
  • 6Gaytan M, Morales C, Bellido C, et al. Non - steroidal anti - inflammatory drugs ( NSAIDs ) and ovulation : lessons from morphology [ J ]. Histol Histopathol, 2006,21 (5) :541 - 556.
  • 7Chan VS. A mechanistic perspective on the specificity and extent of COX - 2 inhibition in pregnancy[J]. Drug Saf,2004,27 (7) :421 - 426.
  • 8Kang H, Kim C, Park E, et al. Meloxicam reduces cycle cancellation rate by premature ovulation in patients with diminished ovarian reserve undergoing natural cycle IVF [ J ]. Human Reproduction, 2010 (6) : 368.
  • 9Bata MS, A1 -Ramahi M, Salhab AS, et al. Delay of ovulation by meloxicam in healthy cycling volunteers : A placebo - controlled, double - blind, crossover study [ J ]. J Clin Pharmacol, 2006,46 (8) : 925 - 932.
  • 10Jesam C, Salvatierra AM, Schwartz JL, et al. Suppression of follicular rupture with meloxicam, a eyclooxygenase -2 inhibitor: potential for emergency contraception [ J ]. Hum Reprod, 2010,25 (2) : 368 - 373.

二级参考文献14

  • 1Juni P, Reiehenbach S,Trelle S,et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial [ J ]. Arthritis Rheum, 2007,56 (11 ) :3610 - 3619.
  • 2Ahman RD. Criteria for classification of clinical osteoarthritis [ J ]. Rheumatol Suppl, 1991 , 18 ( 27 ) : 10 - 12.
  • 3Chu SC, Yang SF, Lue KH,et al. Naproxen, meloxicam and methylprvdnisolone inhibit urokinase plasminogen activalor and inhibitor and gelatinases expression during the early stage of osteoarthritis[ J ]. Clinica Chemica Acta,2008,387 ( 1 - 2) :90 - 91.
  • 4Gunew MN, Menrath VH, Marshall RD. Long-term safety, efficacy and palatability of oral metoxicam at 0. 01 - 0.03mg/kg. for treatment of osteoarthritie pain in cats[ J].Journal of Feline Medicine and Surgery, 2008,10(3) :235 -241.
  • 5Evered D, Whelan JL. Viscosupplementation:a new concept in the treatment of osteoarthritis [ J ]. J Rheumatol, 1993,20 ( suppl 39 ) : 3 - 9.
  • 6Karatosun V, Unver B, Ozden A, et al. Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up [ J ]. Clin Exp Rheumtol,2008,26 ( 2 ) :288 - 294.
  • 7Petrella R J, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraaticular hyalutonic acid for osteoarthritis of the knee [ J ]. J Rheumatol,2006,33 (5) :951 -956.
  • 8袁封文,宋绍勇.美洛昔康治疗骨关节炎的临床疗效[J].中国保健,2006,14(03X):76-76. 被引量:1
  • 9王建春,毛宝龄,陈正堂,孙耕耘,陈维中,李淑平.环氧合酶-2抑制剂对大鼠急性肺损伤的作用[J].中华结核和呼吸杂志,1999,22(6):351-353. 被引量:7
  • 10龙子江,胡文彬.国产美洛昔康片抗炎作用实验研究[J].安徽医科大学学报,2000,35(1):22-23. 被引量:4

共引文献19

同被引文献43

  • 1邓珊.非甾体抗炎药对排卵影响的前瞻性随机对照临床试验[J].实用妇产科杂志,2002(2):95.
  • 2Von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial [ J 1. Lancet, 2002, 360 (9348) : 1803 - 1805.
  • 3Glasier A. Emergency contraception : clinical outcomes [ J ]. Contra- ception, 2013, 87(3): 309-313.
  • 4Lippes J, Mlik T, Tatum H J, et al. The post - coital copper T[ J ]. Adv Plann Parent, 1976,11 ( 3 ) :24 - 29.
  • 5VanLook P. Emergency contraception : history, efficacy, advantages and disadvantages [ J ]. J Reprod Med, 1996,28 (5) :7 - 11.
  • 6Cheng L, Gllmezoglu AM, Piaggio GGP, et al. Interventions for emer- gency contraception [ CD ]. Cochrane Database of systematic Reviews 2008 : CD001324.
  • 7Gemzell - Danielsson K, Meng C. Emergency contraception : Poten- tial role of ulipristal acetate [ J]. Int J Womens Heahh, 2010,2:53 -61.
  • 8Snow SE, Melillo SN, Jarvis CI. Ulipristal acetate for emergency contraception [ J 1- Ann Pharmacother, 2011,45 (6) :780 - 786.
  • 9Faculty of Sexual and Reproductive Health Care. New Product Re- view ( October 2009 ) : ulipristal acetate [ EB/OL 1. [ 2009 - 10 - 30. http://www, ffprhc, org. uk/admin/uploads/42_ ellaOneNew- ProductReviewlO09. pdf.
  • 10Brown A, Cheng L, Lin S, et al . Daily low - dose mifepristonehas contraceptive potential by suppressing ovulation and menstruation: a double blind randomized control trial of 2 and 5 mg per day for 120 days [J]. J Clin Endoerinol Metab, 2002, 87(I): 63-70.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部